Of note, mutations in the PINK1/Parkin pathway were firstly associated with autosomal recessive Parkinson’s disease (Kitada et al., 1998), but, of interest, extensive studies in cardiovascular diseases highlighted that impairment in PINK1/Parkin pathway promotes alterations in the mitophagic flux leading to cardiac dysfunction. This evidence concerns the gene PRKN and cardiovascular disorder.